These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15163253)

  • 1. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes.
    Ketter TA; Kalali AH; Weisler RH;
    J Clin Psychiatry; 2004 May; 65(5):668-73. PubMed ID: 15163253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
    Weisler RH; Kalali AH; Ketter TA;
    J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
    Weisler RH; Keck PE; Swann AC; Cutler AJ; Ketter TA; Kalali AH;
    J Clin Psychiatry; 2005 Mar; 66(3):323-30. PubMed ID: 15766298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
    Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Ketter TA; Keck PE; Swann A; Kalali A;
    CNS Drugs; 2006; 20(3):219-31. PubMed ID: 16529527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():9-14. PubMed ID: 16754406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder.
    Joshi G; Wozniak J; Mick E; Doyle R; Hammerness P; Georgiopoulos A; Kotarski M; Aleardi M; Williams C; Walls S; Biederman J
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):7-14. PubMed ID: 20166791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse event load in bipolar participants receiving either carbamazepine immediate-release or extended-release capsules: a blinded, randomized study.
    El-Mallakh RS; Salem MR; Chopra AS; Mickus GJ; Penagaluri P
    Int Clin Psychopharmacol; 2009 May; 24(3):145-9. PubMed ID: 19367153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of changing from alternative agents to carbamazepine extended-release capsules in bipolar disorder.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():31-4. PubMed ID: 16754411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
    Vasudev K; Goswami U; Kohli K
    Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of response to carbamazepine extended-release capsules treatment in bipolar disorder.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():23-6. PubMed ID: 16754409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical considerations for carbamazepine use in bipolar disorder.
    Fuller MA; Dostrow V; Gupta S; Gazda TD
    Expert Opin Drug Saf; 2006 Jul; 5(4):501-9. PubMed ID: 16774489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A blinded, randomized comparison of immediate-release and extended-release carbamazepine capsules in manic and depressed bipolar subjects.
    El-Mallakh RS; Salem MR; Chopra A; Mickus GJ; Penagaluri P; Movva R
    Ann Clin Psychiatry; 2010 Feb; 22(1):3-8. PubMed ID: 20196977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I Disorder.
    Weisler RH; Kalali AH; Cutler AJ; Gazda TD; Ginsberg L
    Psychiatry (Edgmont); 2008 Mar; 5(3):35-48. PubMed ID: 22778707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.
    Wagner KD; Redden L; Kowatch RA; Wilens TE; Segal S; Chang K; Wozniak P; Vigna NV; Abi-Saab W; Saltarelli M
    J Am Acad Child Adolesc Psychiatry; 2009 May; 48(5):519-532. PubMed ID: 19325497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-release carbamazepine for acute bipolar mania: a review.
    Owen RT
    Drugs Today (Barc); 2006 May; 42(5):283-9. PubMed ID: 16801991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.